The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.
第一作者:
Davide,Rossi
第一单位:
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara.
作者:
主题词
衔接蛋白质类, 信号转导(Adaptor Proteins, Signal Transducing);老年人(Aged);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);多柔比星(Doxorubicin);女(雌)性(Female);基因型(Genotype);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴瘤, 滤泡性(Lymphoma, Follicular);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);核蛋白质类(Nuclear Proteins);多态性, 单核苷酸(Polymorphism, Single Nucleotide);预后(Prognosis);受体, IgG(Receptors, IgG);治疗失败(Treatment Failure);治疗结果(Treatment Outcome)
DOI
10.3324/haematol.2014.108183
PMID
25596266
发布时间
2018-11-13
- 浏览24

Haematologica
517-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文